ArticleMolecular nutrition & food research2025
The Nutrigenomic Effect of Mela Rosa Marchigiana Callus Extract on Cellular Senescence: Insight From a Preliminary In Vitro Study.
Article in Molecular nutrition & food research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Nutrigenomic Effect of Mela Rosa Marchigiana Callus Extract on Cellular Senescence: Insight From a Preliminary In Vitro Study.Molecular nutrition & food research · 2025Article
- Pulp Callus Extract From Malus domestica var. Mela Rosa Marchigiana Preserves Intestinal Barrier Integrity and Confers Neuroprotection in a Gut-Brain Axis Co-Culture Model.BioFactors (Oxford, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Mela Rosa Marchigiana (MRM) is an apple variety cultured in the center of Italy. Calluses derived from in vitro culture of MRM explants were used to obtain an ethanolic extract rich in pentacyclic triterpenic acids with putative anti-inflammatory and anti-aging effects. In this study, we investigated the transcriptomic and epigenetic effects of MRM callus extract (MRME) in an in vitro model of cellular senescence. Senescent HUVECs (sHUVECs) were treated with MRME. Transcriptomic analysis was performed to compare young HUVECs (yHUVECs) with sHUVECs and to evaluate the MRME's effect on sHUVECs. Results show that senescence induces major changes in the transcriptome of HUVECs. MRME downregulates TNF-α signaling genes in sHUVECs restoring the expression to that observed in yHUVECs. Genome-wide DNA methylation analysis performed using the Oxford-Nanopore sequencing platform did not reveal significant changes in DNA methylation levels induced by MRME. Our preliminary results provide additional evidence suggesting that MRME exerts anti-inflammatory and anti-aging effects, which may be mediated by the modulation of the expression of inflammaging genes via mechanisms independent of DNA methylation. These findings highlight MRME as a promising candidate for further in vivo studies aimed at exploring its clinical translational potential in counteracting inflammaging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.